APA (7th ed.) Citation

Z, Z., JM, S., T, Y., PK, V., Y, M., CA, D., . . . M, F. (2020). Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma. Cancers, 12(9), . https://doi.org/10.3390/cancers12092518

Chicago Style (17th ed.) Citation

Z, Zhai, Samson JM, Yamauchi T, Vaddi PK, Matsumoto Y, Dinarello CA, Ravindran Menon D, and Fujita M. "Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma." Cancers 12, no. 9 (2020). https://doi.org/10.3390/cancers12092518.

MLA (9th ed.) Citation

Z, Zhai, et al. "Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma." Cancers, vol. 12, no. 9, 2020, https://doi.org/10.3390/cancers12092518.